Assignee
ESSA PHARMA INC
CA·7 granted patents·12 pending applications·46 citations·filing 2019–2024
Top patents by PatentIndex Score
19 records- 0198US11358938B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Jun 14, 2022·8 cites·26 claims
- 0298US11242324B2Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Feb 8, 2022·9 cites·25 claims
- 0397US11518747B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Dec 6, 2022·6 cites·30 claims
- 0497US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0594US11814357B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Nov 14, 2023·1 cites·22 claims
- 0694US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 0785US2024051926A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 0874US2021323931A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 0972US2024261282A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2024·Application pending·0 cites
- 1069US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 1167US2020123117A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Application pending·0 cites
- 1266US2022105093A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 1362US2023373934A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 1460US2024358701A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1560US2024207264A1Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1658US12109179B2Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Granted Oct 8, 2024·0 cites·23 claims
- 1758US2022380378A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 1852US2023078913A1Androgen receptor modulators and methods for use as proteolysis targeting chimera ligandsESSA PHARMA INC·Filed 2020·Application pending·0 cites
- 1951US2022202780A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ESSA PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →